Trichomonas vaginalis serostatus and prostate cancer risk in Egypt: a case-control study
- 7 November 2020
- journal article
- research article
- Published by Springer Nature in Parasitology Research
- Vol. 120 (4) , 1379-1388
Abstract
Trichomonas vaginalis is one of the most common non-viral sexually transmitted infections (STIs) that has been associated with prostate cancer in some countries. This study aims to investigate if T. vaginalis infection can be a risk factor for prostate cancer in Egypt and its possible relationship with cancer prognostic factors and overall survival. Serum samples were collected from a total of 445 age-matched males; 126 with prostate cancer, 108 with bladder cancer, 91 with different types of cancers, and 120 healthy controls, and then analyzed by ELISA for detection of anti-Trichomonas IgG and prostate-specific antigen (PSA). The results revealed that only 8.3% of controls were seropositive for trichomoniasis, compared with 19% of prostate cancer patients (P = 0.015). There were positive associations between the levels of PSA and tumor stage with T. vaginalis IgG optical density scores among the seropositive cases (P < 0.001 and < 0.05, respectively). However, no significant correlations were detected between seropositivity of T. vaginalis and other prognostic factors or overall survival in those patients. In conclusion, chronic T. vaginalis infection may be associated with prostate cancer, but it does not seem that this STI aggravates the cancer status.Keywords
This publication has 27 references indexed in Scilit:
- Trichomonosis, a Common Curable STI, and Prostate Carcinogenesis—A Proposed Molecular MechanismPLOS Pathogens, 2012
- No Evidence for Infection of UK Prostate Cancer Patients with XMRV, BK Virus, Trichomonas vaginalis or Human Papilloma VirusesPLOS ONE, 2012
- Prospective Study of Trichomonas vaginalis Infection and Prostate Cancer Incidence and Mortality: Physicians' Health StudyJNCI: Journal of the National Cancer Institute, 2009
- Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer MortalityClinical Cancer Research, 2009
- Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention TrialInternational Journal of Cancer, 2009
- Collection, Storage, Retrieval and Distribution of Biological Materials for ResearchCell Preservation Technology, 2008
- Infection withTrichomonas vaginalisIncreases the Risk of HIV‐1 AcquisitionThe Journal of Infectious Diseases, 2007
- Development of an Integrated Prostate Cancer Research Information SystemClinical Genitourinary Cancer, 2006
- Plasma Antibodies against Trichomonas vaginalis and Subsequent Risk of Prostate CancerCancer Epidemiology, Biomarkers & Prevention, 2006
- Is Trichomonas vaginalis a Cause of Cervical Neoplasia? Results from a Combined Analysis of 24 StudiesInternational Journal of Epidemiology, 1994